Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry.

Saved in:
Bibliographic Details
Title: Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry.
Authors: Kutsch N; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Giza A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Robrecht S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Stumpf J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Federhen A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Stoltefuß A; Evangelisches Krankenhaus Hamm, Hamm, Germany., Vehling-Kaiser U; ÜBAG MVZ Dr. Vehling-Kaiser GmbH, Landshut, Germany., Koenigsmann M; Onkologisches Ambulanzzentrum Hannover., Tausch E; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Schneider C; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Stilgenbauer S; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Illmer T; Gemeinschaftspraxis Hämatologie-Onkologie, Dresden, Germany., Schlag R; Hämatologisch-Onkologische Schwerpunktpraxis Würzburg, Würzburg, Germany., Dörfel S; Onkozentrum Dresden Freiberg, Dresden, Germany., Gaska T; Klinik für Hämatologie und Onkologie, Brüderkrankenhaus St. Josef, Paderborn, Germany., Kiehl M; Medizinische Klinik I, Klinikum Frankfurt/Oder, Frankfurt, Germany., Müller-Hagen S; Praxis für Hämatologie und Onkologie in Hamburg, Hamburg, Germany., Moorahrend E; Zentrum für Hämatologie und Onkologie MVZ Porta Westfalica, Porta Westfalica, Germany., Linde H; MVZ für Blut und Krebserkrankungen Potsdam, Potsdam, Germany., Schlenska-Lange A; Barmherzige Brüder Krankenhaus Regensburg, Regensburg, Germany., von Tresckow J; Universitätsklinikum Essen, Essen, Germany., Fischer K; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Eichhorst B; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Hallek M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany., Fink AM; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
Source: European journal of haematology [Eur J Haematol] 2024 Aug; Vol. 113 (2), pp. 235-241. Date of Electronic Publication: 2024 May 01.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1600-0609
DOI:10.1111/ejh.14220